Literature DB >> 8664530

Current trends in etiology, diagnosis, and management of neurocardiogenic syncope.

B P Grubb1, D Kosinski.   

Abstract

Recurrent episodes of unexplained syncope are among the most frequent of complaints referred to physicians for evaluation. Traditional methods of evaluation were both time consuming and expensive and left many patients without a diagnosis. Although neurocardiogenically mediated episodes of hypotension and bradycardia were felt to be a common cause of syncope, this was traditionally a diagnosis of exclusion. The emergence of head-upright tilt-table testing has provide a valuable method for identifying individuals predisposed to neurocardiogenic syncope and has also allowed for a better understanding of this phenomena. This article reviews the pathophysiology of neurocardiogenic syncope, the use of head-upright tilt-table testing in its diagnosis, and the potential therapies used to prevent recurrences.

Entities:  

Mesh:

Year:  1996        PMID: 8664530     DOI: 10.1097/00001573-199601000-00006

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

1.  Inadequate sympathovagal balance in response to orthostatism in patients with unexplained syncope and a positive head up tilt test.

Authors:  C Kouakam; D Lacroix; N Zghal; R Logier; D Klug; P Le Franc; M Jarwe; S Kacet
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 2.  The fainting patient: value of the head-upright tilt-table test in adult patients with orthostatic intolerance.

Authors:  M Lamarre-Cliche; J Cusson
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

3.  Role of carotid sinus syndrome and neurocardiogenic syncope in recurrent syncope and falls in patients referred to an outpatient clinic in a district general hospital.

Authors:  A Eltrafi; D King; J H Silas; P Currie; M Lye
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

4.  A novel psychophysiological treatment for vasovagal syncope.

Authors:  R K Khurana; J J Lynch; F W Craig
Journal:  Clin Auton Res       Date:  1997-08       Impact factor: 4.435

5.  Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope.

Authors:  B P Grubb; B Karas; D Kosinski; K Boehm
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

6.  Midodrine: a role in the management of neurocardiogenic syncope.

Authors:  C R Ward; J C Gray; J J Gilroy; R A Kenny
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

7.  The relationship between clinical characteristics and psychological status and quality of life in patients with vasovagal syncope.

Authors:  Adem Atici; Ramazan Asoglu; Ahmet Demirkiran; Nail Guven Serbest; Baris Emektas; Remzi Sarikaya; Ipek Yeldan; Ahmet Kaya Bilge
Journal:  North Clin Istanb       Date:  2020-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.